MIRA INFORM REPORT

 

 

Report Date :

11.06.2013

 

IDENTIFICATION DETAILS

 

Name :

SAGAR DRUGS AND PHARMACEUTICALS PRIVATE LIMITED

 

 

Registered Office :

38/3 and 46/1, Kanbhakuha Road, Singarwa, Taluka Dascrol, Ahmedabad – 382430, Gujarat

 

 

Country :

India

 

 

Financials (as on) :

31.03.2012

 

 

Date of Incorporation :

26.02.1985

 

 

Com. Reg. No.:

04-007679

 

 

Capital Investment / Paid-up Capital :

Rs. 2.500 Millions

 

 

CIN No.:

[Company Identification No.]

U24231GJ1985PTC007679

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Subject is engaged in the business of manufacturing dyes and dye intermediates.

 

 

No. of Employees :

Information declined by the management

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (47)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 1200000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually Correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having a satisfactory track record. There appears slight dip in its sales during 2012.

 

However, general financial strength seems to be good. Trade relations are reported to be fair. Business is active. Payments are reported to be usually correct and as per commitment.

 

The company can be considered for normal business dealings at usual trade terms and condition.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

INFORMATION DECLINED BY

 

Name :

Ms. Binal Denasri

Designation :

Accountant

Contact No.:

91-79-26308930

Date :

10.06.2013

 

 

LOCATIONS

 

Registered Office :

38/3 and 46/1, Kanbhakuha Road, Singarwa, Taluka Dascrol, Ahmedabad – 382430, Gujarat, India

Tel. No.:

91-79-26308930

Fax No.:

Not Available

E-Mail :

info@sagardrugs.com

 

 

DIRECTORS

 

As on 17.09.2012

 

Name :

Mr. Rohibhai Jayantibhai Patel

Designation :

Managing Director

Address :

D/2, Rajhans Society, Ellisbridge, Ahmedabad- 380006, Gujarat, India

Date of Birth/Age :

27.08.1952

Date of Appointment :

01.10.1998

DIN No.:

0140.3023

 

 

Name :

Mrs. Meenaben Rohitbhai Patel

Designation :

Director

Address :

D/2, Rajhans Society, Ellisbridge, Ahmedabad- 380006, Gujarat, India

Date of Birth/Age :

01.01.1956

Date of Appointment :

20.02.2004

DIN No.:

01367569

 

 

Name :

Mr. Ankur Rohitbhai Patel

Designation :

Whole –time Director

Address :

D/2, Rajhans Society, Ellisbridge, Ahmedabad- 380006, Gujarat, India

Date of Birth/Age :

05.11.1979

Date of Appointment :

29.09.1999

DIN No.:

01367495

 

 

Name :

Mr. Sagar Rohitbhai Patel

Designation :

Director

Address :

D/2, Rajhans Society, Ellisbridge, Ahmedabad- 380006, Gujarat, India

Date of Birth/Age :

17.02.1984

Date of Appointment :

03.03.2003

DIN No.:

01367729

 

 

KEY EXECUTIVES

 

Name :

Ms. Binal Denasri

Designation :

Accountant

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 17.09.2012

 

Names of Shareholders

 

No. of Shares

Sar Investment Private Limited

 

98000

Jay Investment Private Limited

 

97500

Rohitbhai Patel

 

39300

Meenaben Patel

 

100

Ankurbhai Patel

 

5040

Sagarbhai Patel

 

6040

Ankurbhai Patel

 

2000

Sagarbhai Patel

 

2000

Shilpaben Patel

 

20

 

 

 

Total

 

250000

 

Equity Share Break up (Percentage of Total Equity)

 

As on 17.09.2012

 

Category

Percentage

Bodies corporate

78.20

Directors or relatives of Directors

21.80

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Subject is engaged in the business of manufacturing dyes and dye intermediates.

 

PRODUCTION STATUS (As on 31.03.2011)

 

Particulars

Unit

**Installed Capacity

**Actual Production

Dye intermediates

M.T

5320

1017

 

Note: Certified by the Company and being technical matter not verified by Auditors.

 

GENERAL INFORMATION

 

No. of Employees :

Information declined by the management

 

 

Bankers :

Bank of India, Ahmedabad Main Branch Mezzanine Floor, Bank of India Building Bhadra, Ahmedabad – 380001, Gujarat, India

 

 

Facilities :

Secured Loan

31.03.2012

(Rs. in Millions)

31.03.2011

(Rs. in Millions)

Deferred Payment Liabilities

 

 

Vehicle Hire Purchase Loans

1.966

4.563

Less: Loan installments payable within one year

1.862

0.000

Total

0.104

4.563

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Darshan Shah and Associates

Chartered Accountants

Address :

A-6, Ground Floor, Vasupuya Chambers, Income Tax, Ashram Road, Ahmedabad – 380014, Gujarat, India

PAN No.:

ABIPS3385F

 

 

Associates/Subsidiaries :

Gpsar Healthcare Limited

CIN: U24230GJ1999PLC035606

 

 

CAPITAL STRUCTURE

 

As on 31.03.2012

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

250000

Equity Shares

Rs.10/- each

Rs. 2.500 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

250000

Equity Shares

Rs.10/- each

Rs. 2.500 Millions

 

 

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2012

31.03.2011

31.03.2010

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

2.500

2.500

2.500

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

303.954

299.213

297.171

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

306.454

301.713

299.671

LOAN FUNDS

 

 

 

1] Secured Loans

0.104

4.563

2.820

2] Unsecured Loans

19.371

43.260

56.604

TOTAL BORROWING

19.475

47.823

59.424

DEFERRED TAX LIABILITIES

0.000

0.000

0.000

 

 

 

 

TOTAL

325.929

349.536

359.095

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

32.815

34.396

36.868

Capital work-in-progress

7.374

1.384

0.000

 

 

 

 

INVESTMENT

58.175

100.324

104.001

DEFERRED TAX ASSETS

0.677

0.574

1.179

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

35.912

36.634

26.828

 

Sundry Debtors

32.647

20.322

28.790

 

Cash & Bank Balances

21.057

12.317

4.775

 

Other Current Assets

1.723

3.226

0.846

 

Loans & Advances

156.752

162.341

173.598

Total Current Assets

248.091

234.840

234.837

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

13.930

10.570

11.449

 

Other Current Liabilities

6.961

11.100

6.025

 

Provisions

0.312

0.312

0.316

Total Current Liabilities

21.203

21.982

17.790

Net Current Assets

226.888

212.858

217.047

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.000

 

 

 

 

TOTAL

325.929

349.536

359.095

 

 


PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2012

31.03.2011

31.03.2010

 

SALES

 

 

 

 

Income

126.120

133.402

 

 

 

Other Income

11.993

14.886

 

 

 

TOTAL                                     (A)

138.113

148.288

160.978

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of Material Consumed

65.485

65.292

 

 

 

Purchase of Trading  Goods

4.132

0.315

 

 

 

Purchase of Trading  Goods

(c) Changes In inventories of Finished  Goods, Work-in-progress and Stock- in--trade

-2.579

-2.662

 

 

 

Employee Benefits  Expenses

8.364

10.268

 

 

 

Other Expenses

51.555

63.203

 

 

 

TOTAL                                     (B)

126.957

136.416

174.786

(Including Financial Expenses)

 

 

 

 

 

Less

PROFIT / (LOSS) BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)     (C)

11.156

11.872

 

 

 

 

 

 

Less

FINANCIAL EXPENSES                                    (D)

0.704

0.611

 

 

 

 

 

 

 

PROFIT / (LOSS)  BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                               (E)

10.452

11.261

(13.808)

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

5.523

4.773

5.247

 

 

 

 

 

 

PROFIT / (LOSS)  BEFORE TAX (E-F)             (G)

4.929

6.488

(19.055)

 

 

 

 

 

Less

TAX                                                                  (H)

(0.103)

4.155

(0.003)

 

 

 

 

 

 

PROFIT / (LOSS)  AFTER TAX (G-H)                 (I)

5.032

2.333

(19.052)

 

 

 

 

 

 

APPROPRIATIONS

 

 

 

 

 

Transfer to General Reserve

2.500

2.500

2.500

 

 

Dividend

0.250

0.250

0.250

 

 

Corporate Tax on Dividend

0.041

0.041

0.042

 

BALANCE CARRIED TO THE B/S

266.305

264.064

264.522

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

35.515

74.727

73.691

 

 

 

 

 

 

Earnings/ (Loss)  Per Share (Rs.)

20.13

9.33

(76.21)

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2012

31.03.2011

31.03.2010

PAT / Total Income

(%)

3.64

1.57

(11.84)

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

3.91

4.86

NA

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

1.99

2.76

(8.11)

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.02

0.02

(0.06)

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

0.06

0.16

0.20

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

11.70

10.68

13.20

 

 

LOCAL AGENCY FURTHER INFORMATION

 

SUNDRY CREDITORS DETAILS:

 

Particulars

31.03.2012

31.03.2011

31.03.2010

 

(Rs. In Millions)

Sundry Creditors

13.930

10.570

11.449

 

 

 

 

Total

13.930

10.570

11.449

 

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

--

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

--

22]

Litigations that the firm / promoter involved in

--

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

--

26]

Buyer visit details

--

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

OPERATIONS

 

During the year, the Company has earned income of Rs. 138.100 Millions against Rs. 148.300 Millions in the previous year. The Company had earned Profit after Tax of Rs 5.032 Millions as compared to the profit after Tax of Rs. 2.333 Millions in the previous year. The directors are hopeful to make a improve the position in the coming years.

 

FUTURE PROSPECTUS

 

The outcome of the research and development of the products of the company has shown good results and new products being developed by the company are accepted in the international market from quality and cost point of view. The Directors are confident to achieve better result in future.

 

SUBSIDIAIIY COMPANIES

 

M/s. SAR Oraganisers Private Limited is the wholly owned subsidiary and M/s. GPSAR Healthcare Limited is the subsidiary company of the Company. The audited copy of accounts of above subsidiaries is attached for the information. The investment in SAR Organizers Private Limited is 99.99% and the investment in GPSAR Healthcare Limited is 52%

 

CORPORATE INFORMATION

 

The Company is engaged in the business of manufacturing dyes and dye intermediates.

 

These financial statements have been prepared on an accrual basis and under historical cost convention and in compliance, in all material aspects, with the applicable accounting principles in  India, the applicable accounting standards notified under Section 211 (3C) and the other relevant provisions of the Companies Act, 1956.

 

All the assets and liabilities have been classified as current or non-current as per the Company's normal operating cycle and other criteria set out in Schedule VI to the Companies Act, 1956. Based on the nature of products and the time between the acquisition of assets for processing and their realization in cash and cash equivalent, the Company has ascertained its operating cycle to be less than 12 months

 

UNSECURED LOAN

 

PARTICULARS

31.03.2012

(Rs. in Millions)

31.03.2011

(Rs. in Millions)

Installment payable within one year

1.862

0.000

Loan from Directors

17.509

43.260

Total

19.371

43.260

 

 

BANKERS CHARGES REPORT AS PER REGISTRY

 

Corporate identity number of the company

U24231GJ1985PTC007679

Name of the company

SAGAR DRUGS AND PHARMACEUTICALS PRIVATE LIMITED

Address of the registered office or of the principal place of  business in India of the company

38/3 and 46/1, Kanbhakuha Road, Singarwa, Taluka Dascrol, Ahmedabad – 382430, Gujarat, India

 

Email: info@sagardrugs.com 

This form is for

Creation of charge

Modification of charge

Charge identification (ID) number of the charge to be modified

90100039

Type of charge

·         Immovable property

·         Any interest in immovable property

Particular of charge holder

CIN: U24231GJ1985PTC007679

 

Bank of India, Ahmedabad Main Branch Mezzanine Floor, Bank of India Building Bhadra, Ahmedabad – 380001, Gujarat, India

 

Email: ahmedabad.ahmedabad@bankofindia.co.in

Nature of instrument creating charge

Supplemental memorandum of entry for extension of equitable mortgage charge on immovable properties executed by the company to secure the modified and revised fund based and non fund based total aggregate credit facilities of Rs. 27.500 Millions registered with SRO Ahmedabad - 12 (Nikol) at Sr No 4050 of book no 1 on 25.04.2012 containing 27 pages

Date of instrument Creating the charge

25.04.2012

Amount secured by the charge

Rs. 27.500 Millions

Brief of the principal terms an conditions and extent and operation of the charge

Rate of Interest

CC STK / BD - 2.75% Above BR Presently 13.25% P. A. On Monthly Rest Basis or such other rate as may BE pres by bk fm time to time EPC / FBP / FBN / IBP / IBN / LC / GUA - AS Per BK rules

 

Terms of Repayment

CC Stocks / CC BK DTS - ON Demand/ Annual Review EPC -  ON Demand/ Annual Review

FBP / FBN / IBP / IBN - ON Demand/ Annual Review

LC - ON Demand/ Annual Review Bank Guarantee - On Demand/ Annual Review

 

Margin

CC Stocks - 25%, CC Book Debts - 40%

EPC - 10%, FBP / FBN - NIL, IBP / IBN - 10%

LC - 25%, GUA - 10%

 

Extent and Operation of the charge

First and exclusive charge by way of equitable mortgage extended / modified on all immovable properties being building, sheds, structures, const and fixed plant and machinery of the company in favour of boi to secure the modified and revised fund based and nonf fund based total aggregate facilities of Rs. 27.500 Millions along with interest, additional interest penal interest liquidated damages, costs, charges, commission and all other amt due to the bank from time to time of what so ever nature.

 

Others

Amt Rs In Millions

Existing Limits Rs 31.000

Revised Limits  Rs. 27.500

Short particulars of the property or asset(s) charged (including complete address and location of the property)

All The Peice and Parcel Of Prop Being Bldg, Const, Sheds, Super Structures Adm 4012 Sq Mtr With All Amenities Const On Land Sur No 38/3 and Sur No 46/1 Mouje Singarva Taluka Dascroi District Ahmedabad

Date of instrument modifying the charge

12.05.2005

Particulars of the present modification

Bank has granted additional credit facilities of Rs. 61.000 Millions with max modified and revised fb + nfb aggregate limits to Rs. 27.500 Millions and thereby total aggregate fb and nfb limits are modified and revised fm Rs 31.000 Millions to Rs. 27.500 Millions and thus equitable mortgage on immovable properties of the co being buildings, sheds, structures and constr and fixed plant and mach will extend and operate for Rs. 27.500 Millions w. E. F. 25.04.2012.

 

FIXED ASSETS

 

Tangible Assets

 

  • Land
  • Building
  • Roads and Machinery
  • Plant and Machines
  • Office Equipments
  • Computers
  • Furniture and Fixtures
  • Vehicle

 

Intangible Assets

 

  • Trade Mark Development
  • Computer Software

 

 


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.57.78

UK Pound

1

Rs.89.71

Euro

1

Rs.76.24

 

 

INFORMATION DETAILS

 

Information Gathered by :

SVA

 

 

Report Prepared by :

KVT

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

6

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILIRY

1~10

5

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

6

--CREDIT LINES

1~10

5

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

47

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NB

NEW BUSINESS

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.